Benefits of leukemia treatment may outweigh risks
Researchers reviewed data from two dozen studies on allogeneic stem cell transplantation, in which blood-forming donor cells replace abnormal cells in a patient's bone marrow. The procedure has a high risk of serious side effects.
Posted — UpdatedUsing a strong treatment to cure leukemia patients has been limited because of serious, potentially fatal side effects. But researchers from the Dana-Farber Cancer Institute have found the benefits of allogeneic stem cell transplantation may outweigh the risks.
The initial treatment for acute myleloid leukemia (AML) is chemotherapy. It helps nearly 70 percent of patients under 60 years old go into remission.
The best way to prevent a relapse is unclear, so researchers studied allogeneic stem cell transplantation.
Researchers say that the development of a more sophisticated means of analyzing genetic risk will help to further pinpoint ideal candidates for this type of stem cell transplant.
• Credits
Copyright 2024 JAMA. All rights reserved.